Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma

BACKGROUND: Ipilimumab improves overall survival in a subset of patients with metastatic melanoma. Peripheral blood T cell receptor (TCR) repertoire diversity has been associated with favorable outcomes in patients with cancer, but its relevance as a biomarker for ipilimumab outcomes remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Postow, Michael A., Manuel, Manuarii, Wong, Phillip, Yuan, Jianda, Dong, Zhiwan, Liu, Cailian, Perez, Solène, Tanneau, Isabelle, Noel, Marlène, Courtier, Anaïs, Pasqual, Nicolas, Wolchok, Jedd D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469400/
https://www.ncbi.nlm.nih.gov/pubmed/26085931
http://dx.doi.org/10.1186/s40425-015-0070-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469400/
https://www.ncbi.nlm.nih.gov/pubmed/26085931
http://dx.doi.org/10.1186/s40425-015-0070-4

Ejemplares similares